Ayala Pharmaceuticals Inc (ADXS)

[ignatiusrielly35]

I would bet that Amgen would not relish having ADXS acquired by another BP at all. Why would they? What I was suggesting is that Amgen might rather have control of the development of NEO (and probably HOT) instead of having ADXS control it. The competition is coming, and I'm sure Amgen believes they could do it quicker and better than ADXS management. And they would probably be correct. Thus, it is not hard to see this as a motivating factor for an Amgen buyout, in addition to its saving of the $450 in milestones, plus future royalties, not to mention acquiring all rights to HOT, AXAL, PSA, etc.